These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 28974406)

  • 21. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
    Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
    BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional collagenase
    Chung E; Wang J
    Investig Clin Urol; 2022 Sep; 63(5):563-568. PubMed ID: 36068002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
    Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
    Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners.
    Goldstein I; Knoll LD; Lipshultz LI; Smith T; Kaufman GJ; McMahon CG
    Sex Med; 2017 Jun; 5(2):e124-e130. PubMed ID: 28395998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
    Dhillon S
    Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
    Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
    J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of collagenase Clostridium histolyticum combination therapies for Peyronie's disease: a systematic review and meta-analysis.
    Guo Y; Yang Y; Mao Q; Liu H; Wang T; Sun F; Wu J; Cui Y
    Sex Med Rev; 2024 Jun; 12(3):497-504. PubMed ID: 38650382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
    Natale C; McLellan DM; Yousif A; Hellstrom WJG
    Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Collagenase Clostridium histolyticum (Xiapex
    Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
    Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
    Gabrielson AT; Spitz JT; Hellstrom WJG
    Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
    Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
    BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
    Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
    J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of collagenase Clostridium histolyticum in men with congenital penile curvature.
    Kulkarni Y; Green B; Pattillo C; Stirland I; Flores A; Ziegelmann M; Kohler T; Helo S; Trost L
    J Sex Med; 2023 Feb; 20(2):194-199. PubMed ID: 36763911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature.
    Masterson TA; Rezk A; Ramasamy R
    World J Urol; 2020 Feb; 38(2):279-285. PubMed ID: 31250098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis.
    Nguyen HMT; Yousif A; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M; Hellstrom WJG
    Urology; 2020 Nov; 145():147-151. PubMed ID: 32777367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
    Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
    Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.